[go: up one dir, main page]

SE8701004D0 - METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES - Google Patents

METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES

Info

Publication number
SE8701004D0
SE8701004D0 SE8701004A SE8701004A SE8701004D0 SE 8701004 D0 SE8701004 D0 SE 8701004D0 SE 8701004 A SE8701004 A SE 8701004A SE 8701004 A SE8701004 A SE 8701004A SE 8701004 D0 SE8701004 D0 SE 8701004D0
Authority
SE
Sweden
Prior art keywords
leukemias
malignancies
therapy
certain
man
Prior art date
Application number
SE8701004A
Other languages
Swedish (sv)
Inventor
M Jondal
A Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE8701004A priority Critical patent/SE8701004D0/en
Publication of SE8701004D0 publication Critical patent/SE8701004D0/en
Priority to AU14878/88A priority patent/AU621046B2/en
Priority to JP63502593A priority patent/JPH01502592A/en
Priority to FI885177A priority patent/FI885177A0/en
Priority to PCT/SE1988/000118 priority patent/WO1988006891A1/en
Priority to EP88902603A priority patent/EP0305468A1/en
Priority to NO885015A priority patent/NO885015L/en
Priority to DK626788A priority patent/DK626788A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2033—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A method for the treatment of malignantly transformed cells in animals and man, which comprises the administration of a therapeutically adequate amount of specified B-cell growth and differentiation factors.
SE8701004A 1987-03-11 1987-03-11 METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES SE8701004D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8701004A SE8701004D0 (en) 1987-03-11 1987-03-11 METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES
AU14878/88A AU621046B2 (en) 1987-03-11 1988-03-10 Method for therapy of leukemias and certain other malignancies
JP63502593A JPH01502592A (en) 1987-03-11 1988-03-10 How to treat leukemia and certain malignant tumors
FI885177A FI885177A0 (en) 1987-03-11 1988-03-10 FOERFARANDE FOER BEHANDLING AV LEUKEMIER OCH VISSA ANDRA FORMER AV CANCER.
PCT/SE1988/000118 WO1988006891A1 (en) 1987-03-11 1988-03-10 Method for therapy of leukemias and certain other malignancies
EP88902603A EP0305468A1 (en) 1987-03-11 1988-03-10 B-cell growth and differentiating factor BCGF 12K for use in therapy
NO885015A NO885015L (en) 1987-03-11 1988-11-10 METHOD OF TREATMENT OF LEUKEMIES AND CERTAIN OTHER DEPARTURES.
DK626788A DK626788A (en) 1987-03-11 1988-11-10 PROCEDURES FOR TREATING LEUKAEMIES AND CERTAIN OTHER MILK CONDITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701004A SE8701004D0 (en) 1987-03-11 1987-03-11 METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES

Publications (1)

Publication Number Publication Date
SE8701004D0 true SE8701004D0 (en) 1987-03-11

Family

ID=20367826

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701004A SE8701004D0 (en) 1987-03-11 1987-03-11 METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES

Country Status (6)

Country Link
EP (1) EP0305468A1 (en)
JP (1) JPH01502592A (en)
AU (1) AU621046B2 (en)
FI (1) FI885177A0 (en)
SE (1) SE8701004D0 (en)
WO (1) WO1988006891A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
GB8808015D0 (en) 1988-04-06 1988-05-05 Ritter M A Chemical compounds
EP0454736A4 (en) * 1989-01-20 1993-05-12 The University Of Melbourne Fibrinolysis
JP2704546B2 (en) * 1989-04-04 1998-01-26 光利 太良 ATLL therapeutic inhalant
KR100191223B1 (en) * 1989-07-28 1999-06-15 둘락 노먼 씨. Method for Purifying Interleukin-4 and Pharmaceutical Composition Containing the Same
FR2653020B1 (en) * 1989-10-17 1993-03-26 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA.
GB9001625D0 (en) * 1990-01-24 1990-03-21 Ciba Geigy Ag A pharmaceutical preparation for maturation of prothymocytes
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
EP0557420A1 (en) * 1990-11-16 1993-09-01 Schering Corporation Method for inducing maturation of myeloid cells with interleukin-5
MX9205233A (en) * 1991-09-16 1993-12-01 Schering Corp USE OF IL-5 TO TREAT SOLID TUMORS.
DE69433820T2 (en) * 1993-12-23 2005-06-23 Immunex Corp., Seattle USE OF SOLUBLE OLIGOMERIC CD40 LIGANDS OR MONOCLONAL ANTIBODIES FOR THE MANUFACTURE OF A MEDICINE FOR PREVENTING OR TREATING NEOPLASTIC DISEASES
US7033589B1 (en) 1997-02-20 2006-04-25 Biogen Idec Ma Inc. γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US6893636B2 (en) 1997-02-20 2005-05-17 Biogen Idec Ma Inc. Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
WO2017156349A1 (en) 2016-03-10 2017-09-14 Cold Genesys, Inc. Methods of treating solid or lymphatic tumors by combination therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077571A3 (en) * 1981-10-19 1983-10-12 Ajinomoto Co., Inc. Process for producing a lymphokine
JPH0637520B2 (en) * 1985-07-03 1994-05-18 味の素株式会社 Polypeptide
US4882282A (en) * 1985-08-16 1989-11-21 Immunex Corporation DNA sequences encoding bovine interleukin-2
JPH0763361B2 (en) * 1985-10-15 1995-07-12 三井東圧化学株式会社 Cultured cell line
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
WO1987004466A1 (en) * 1986-01-15 1987-07-30 Amersham International Plc Interleukin
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
WO1988006891A1 (en) 1988-09-22
JPH01502592A (en) 1989-09-07
AU1487888A (en) 1988-10-10
FI885177A7 (en) 1988-11-10
AU621046B2 (en) 1992-03-05
FI885177L (en) 1988-11-10
EP0305468A1 (en) 1989-03-08
FI885177A0 (en) 1988-11-10

Similar Documents

Publication Publication Date Title
SE8701004D0 (en) METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES
IT1208521B (en) ELECTRODE, APPARATUS AND DEFIBRILLATION FOR IMPLANTATION IN HUMAN OR ANIMAL BODIES.
FI881876A7 (en) Method for preparing a composition for use in the treatment of neurological diseases.
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
DE69009280D1 (en) Implantable device with 24-hour rhythm control.
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
AU8091787A (en) The use of paroxetine to treat pain
EP0228448A4 (en) Use of biologically active copolymers for the manufacture of a medicament for stimulating the growth of an animal.
ZA87884B (en) Therapeutic agent
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
GR3004464T3 (en) Use of paf-antagonists for the preparation of a medicament and method for the determination of their binding-activity
DE3361812D1 (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
GB2211389B (en) Procedure for the treatment of pigs in slaughterhouses, and system for the stalling of pigs
GR3006674T3 (en)
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
GR3001277T3 (en) Chlorpheniramine therapy
AU2661588A (en) Method for treating hoof thrush and hoof rot
HUT40915A (en) Therapeutic process
ZA857721B (en) Process for treatment of rheumatic diseases
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
JPS57119744A (en) Therapeutic tool implanted in body
PT91610A (en) PROCESS FOR THE PREPARATION OF COMPOUNDS FOR THE TREATMENT OF RHEUMATOIDAL ARTERITIS
GR3002328T3 (en) 2-(benzhydrylsulfonyl) acetamide, process for its preparation and its therapeutical use
RU96112579A (en) METHOD FOR MODELING DIPHTERIUS MYOCARDITIS